A high resolution genome-wide scan of HNF4α recognition sites infers a regulatory gene network in colon cancer

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Weltmeier, Fridtjof ^a   Borlak, Juergen ^a,b  

^a FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ESTROGEN RECEPTOR ALPHA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; DNA BINDING PROTEIN; HEPATOCYTE NUCLEAR FACTOR 4; HNF4A PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; COLON CANCER; CONTROLLED STUDY; DISEASE COURSE; DNA BINDING; DNA DETERMINATION; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; GENE MAPPING; GENE TARGETING; GENETIC ALGORITHM; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REGULATOR GENE; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION; COLON TUMOR; DNA MICROARRAY; ENHANCER REGION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; HUMAN GENOME; METABOLISM; PROMOTER REGION; PROTEIN BINDING; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE;

BINDING SITES; CHROMATIN IMMUNOPRECIPITATION; COLONIC NEOPLASMS; DNA, NEOPLASM; DNA-BINDING PROTEINS; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENOME, HUMAN; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 79960876540     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021667     Document Type: Article

References (48)

1. Schrem H, Klempnauer J, Borlak J, (2002) Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression. Pharmacol Rev 54: 129-158.
2. Jiang G, Lee U, Sladek FM, (1997) Proposed mechanism for the stabilization of nuclear receptor DNA binding via protein dimerization. Mol Cell Biol 17: 6546-6554.
3. Rada-Iglesias A, Wallerman O, Koch C, Ameur A, Enroth S, et al. (2005) Binding sites for metabolic disease related transcription factors inferred at base pair resolution by chromatin immunoprecipitation and genomic microarrays. Hum Mol Genet 14: 3435-3447.
4. Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, et al. (2004) Control of pancreas and liver gene expression by HNF transcription factors. Science 303: 1378-1381.
5. Delie F, Rubas W, (1997) A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Crit Rev Ther Drug Carrier Syst 14: 221-286.
6. Soutoglou E, Talianidis I, (2002) Coordination of PIC assembly and chromatin remodeling during differentiation-induced gene activation. Science 295: 1901-1904.
7. Niehof M, Borlak J, (2008) EPS15R, TASP1, and PRPF3 are novel disease candidate genes targeted by HNF4alpha splice variants in hepatocellular carcinomas. Gastroenterology 134: 1191-1202.
8. Cawley S, Bekiranov S, Ng HH, Kapranov P, Sekinger EA, et al. (2004) Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116: 499-509.
9. Johnson WE, Li W, Meyer CA, Gottardo R, Carroll JS, et al. (2006) Model-based analysis of tiling-arrays for ChIP-chip. Proc Natl Acad Sci U S A 103: 12457-12462.
10. Ji H, Wong WH, (2005) TileMap: create chromosomal map of tiling array hybridizations. Bioinformatics 21: 3629-3636.
11. Kel AE, Gössling E, Reuter I, Cheremushkin E, Kel-Margoulis OV, et al. (2003) MATCH: A tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res 31: 3576-3579.
12. Xu X, Bieda M, Jin VX, Rabinovich A, Oberley MJ, et al. (2007) A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members. Genome Res 17: 1550-1561.
13. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, et al. (2006) Genome-wide analysis of estrogen receptor binding sites. Nat Genet 38: 1289-1297.
14. Bieda M, Xu X, Singer MA, Green R, Farnham PJ, (2006) Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome. Genome Res 16: 595-605.
15. Bolton EC, So AY, Chaivorapol C, Haqq CM, Li H, et al. (2007) Cell- and gene-specific regulation of primary target genes by the androgen receptor. Genes Dev 21: 2005-2017.
16. West AG, Fraser P, (2005) Remote control of gene transcription. Hum Mol Genet 14 Spec No 1: R101-11.
17. Dekker J, (2008) Gene regulation in the third dimension. Science 319: 1793-1794.
18. Spilianakis CG, Lalioti MD, Town T, Lee GR, Flavell RA, (2005) Interchromosomal associations between alternatively expressed loci. Nature 435: 637-645.
19. Dongol B, Shah Y, Kim I, Gonzalez FJ, Hunt MC, (2007) The acyl-CoA thioesterase I is regulated by PPARalpha and HNF4alpha via a distal response element in the promoter. J Lipid Res 48: 1781-1791.
20. Hertz R, Bishara-Shieban J, Bar-Tana J, (1995) Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III. J Biol Chem 270: 13470-13475.
21. Hertz R, Seckbach M, Zakin MM, Bar-Tana J, (1996) Transcriptional suppression of the transferrin gene by hypolipidemic peroxisome proliferators. J Biol Chem 271: 218-224.
22. Watt AJ, Garrison WD, Duncan SA, (2003) HNF4: a central regulator of hepatocyte differentiation and function. Hepatology 37: 1249-1253.
23. Sladek FM, (1993) Orphan receptor HNF-4 and liver-specific gene expression. Receptor 3: 223-232.
24. Battle MA, Konopka G, Parviz F, Gaggl AL, Yang C, et al. (2006) Hepatocyte nuclear factor 4alpha orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver. Proc Natl Acad Sci U S A 103: 8419-8424.
25. Chiba H, Gotoh T, Kojima T, Satohisa S, Kikuchi K, et al. (2003) Hepatocyte nuclear factor (HNF)-4alpha triggers formation of functional tight junctions and establishment of polarized epithelial morphology in F9 embryonal carcinoma cells. Exp Cell Res 286: 288-297.
26. Parviz F, Matullo C, Garrison WD, Savatski L, Adamson JW, et al. (2003) Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet 34: 292-296.
27. Miura A, Yamagata K, Kakei M, Hatakeyama H, Takahashi N, et al. (2006) Hepatocyte nuclear factor-4alpha is essential for glucose-stimulated insulin secretion by pancreatic beta-cells. J Biol Chem 281: 5246-5257.
28. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, et al. (1996) Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature 384: 458-460.
29. Grigo K, Wirsing A, Lucas B, Klein-Hitpass L, Ryffel GU, (2008) HNF4 alpha orchestrates a set of 14 genes to down-regulate cell proliferation in kidney cells. Biol Chem 389: 179-187.
30. Lucas B, Grigo K, Erdmann S, Lausen J, Klein-Hitpass L, et al. (2005) HNF4alpha reduces proliferation of kidney cells and affects genes deregulated in renal cell carcinoma. Oncogene 24: 6418-6431.
31. Naiki T, Nagaki M, Shidoji Y, Kojima H, Imose M, et al. (2002) Analysis of gene expression profile induced by hepatocyte nuclear factor 4alpha in hepatoma cells using an oligonucleotide microarray. J Biol Chem 277: 14011-14019.
32. Sumi K, Tanaka T, Uchida A, Magoori K, Urashima Y, et al. (2007) Cooperative interaction between hepatocyte nuclear factor 4 alpha and GATA transcription factors regulates ATP-binding cassette sterol transporters ABCG5 and ABCG8. Mol Cell Biol 27: 4248-4260.
33. Harbison CT, Gordon DB, Lee TI, Rinaldi NJ, Macisaac KD, et al. (2004) Transcriptional regulatory code of a eukaryotic genome. Nature 431: 99-104.
34. Borlak J, Thum T, (2001) Induction of nuclear transcription factors, cytochrome P450 monooxygenases, and glutathione S-transferase alpha gene expression in Aroclor 1254-treated rat hepatocyte cultures. Biochem Pharmacol 61: 145-153.
35. Lazarevich NL, Cheremnova OA, Varga EV, Ovchinnikov DA, Kudrjavtseva EI, et al. (2004) Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors. Hepatology 39: 1038-1047.
36. Cheng AS, Jin VX, Fan M, Smith LT, Liyanarachchi S, et al. (2006) Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters. Mol Cell 21: 393-404.
37. Michelson AM, (2002) Deciphering genetic regulatory codes: a challenge for functional genomics. Proc Natl Acad Sci U S A 99: 546-548.
38. Fourel G, Ringeisen F, Flajolet M, Tronche F, Pontoglio M, et al. (1996) The HNF1/HNF4-dependent We2 element of woodchuck hepatitis virus controls viral replication and can activate the N-myc2 promoter. J Virol 70: 8571-8583.
39. Harnish DC, Malik S, Kilbourne E, Costa R, Karathanasis SK, (1996) Control of apolipoprotein AI gene expression through synergistic interactions between hepatocyte nuclear factors 3 and 4. J Biol Chem 271: 13621-13628.
40. Birney E, Stamatoyannopoulos JA, Dutta A, Guigó R, et al. ENCODE Project Consortium (2007) Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447: 799-816.
41. Niehof M, Borlak J, (2005) RSK4 and PAK5 are novel candidate genes in diabetic rat kidney and brain. Mol Pharmacol 67: 604-611.
42. Niehof M, Borlak J, (2008) HNF4 alpha and the Ca-channel TRPC1 are novel disease candidate genes in diabetic nephropathy. Diabetes 57: 1069-1077.
43. Ji X, Li W, Song J, Wei L, Liu XS, (2006) CEAS: cis-regulatory element annotation system. Nucleic Acids Res 34 (Web Server issue): W551-554.
44. Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, et al. (2005) Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res 15: 1034-1050.
45. Tong W, Cao X, Harris S, Sun H, Fang H, et al. (2003) ArrayTrack-supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research. Environ Health Perspect 111: 1819-1826.
46. Rohrbeck A, Borlak J, (2009) Cancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1. PLoS One 4: e7315.
47. Giardine B, Riemer C, Hardison RC, Burhans R, Elnitski L, et al. (2005) Galaxy: a platform for interactive large-scale genome analysis. Genome Res 15: 1451-1455.
48. Kankainen M, Holm L, (2004) POBO, transcription factor binding site verification with bootstrapping. Nucleic Acids Res 32 (Web Server issue): W222-229.